AbbVie Has Immense Cash Flow Potential - Seeking Alpha

1 day ago · AbbVie Has Immense Cash Flow Potential. Jan. 14, 2025 5:08 AM ET AbbVie Inc. (ABBV) Stock, ... Seeking Alpha's Disclosure: Past performance is no guarantee of future …

$18.64
OFF

AbbVie (ABBV): A Strong Investment Opportunity In ... - Seeking …

2 weeks from now

Oct 3, 2024 · It also maintains healthy cash flows, generating $18.64 billion in operating cash flow over the last twelve months. AbbVie has consistently delivered a substantial dividend payout, …

seekingalpha.com

95%
OFF

Despite Neuroscience Setback, AbbVie Has Strong Recovery Ahead

2 weeks from now

Nov 25, 2024 · AbbVie’s promising pipeline and 3.95% dividend yield offer growth potential. Read why ABBV stock could thrive despite the Emraclidine trial failure.

seekingalpha.com

$7
OFF

Where Will AbbVie Be In 5 Years? - The Motley Fool

2 weeks from now

Nov 19, 2024 · It currently has more than $7.2 billion in cash, equivalents, and short-term investments, and in 2023 it reported free cash flow (FCF) of nearly $22.1 billion. So it should …

fool.com

$41
OFF

Decoding AbbVie Inc (ABBV): A Strategic SWOT Insight - Yahoo …

2 weeks from now

Nov 5, 2024 · AbbVie has demonstrated a robust financial performance with worldwide net revenues of $41.2 billion, operating earnings of $10.6 billion, and cash flows from operations …

yahoo.com

$0.88
OFF

AbbVie Reports Third-Quarter 2024 Financial Results | AbbVie

2 weeks from now

Oct 30, 2024 · Reports Third-Quarter Diluted EPS of $0.88 on a GAAP Basis, a Decrease of 12.0 Percent; Adjusted Diluted EPS of $3.00, an Increase of 1.7 Percent; These Results Include an …

abbvie.com

$2.95
OFF

Investors Heavily Search AbbVie Inc. (ABBV): Here Is What You

2 weeks from now

Sep 27, 2024 · AbbVie is expected to post earnings of $2.95 per share for the current quarter, representing no change from the year-ago quarter. Over the last 30 days, the Zacks …

nasdaq.com

28%
OFF

AbbVie (ABBV) Performance History & Total Returns

2 weeks from now

Jan 7, 2024 · The total return for AbbVie (ABBV) stock is 15.28% over the past 12 months. So far it's up 1.03% this year. Includes price appreciation + reinvested dividends. ... TTM free cash …

financecharts.com

32%
OFF

AbbVie Cash Flow From Investing Activities 2010-2024 | ABBV

2 weeks from now

AbbVie cash flow from investing activities for the twelve months ending September 30, 2024 was $-41.233B, a 1200.32% increase year-over-year. AbbVie annual cash flow from investing …

macrotrends.net

94%
OFF

AbbVie Cash Flow From Financial Activities 2010-2024 | ABBV

2 weeks from now

AbbVie cash flow from financial activities for the twelve months ending September 30, 2024 was $-31M, a 99.94% decline year-over-year. AbbVie annual cash flow from financial activities for …

macrotrends.net

FAQs about AbbVie Has Immense Cash Flow Potential - Seeking Alpha Coupon?

What is the fiscal year of AbbVie Inc (abbv)?

Fiscal year is January - December. Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual ( 10-K) and quarterly ( 10-Q) reports submitted to the Securities and Exchange Commission (SEC). Detailed cash flow statements for AbbVie Inc. (ABBV), including operating cash flow, capex and free cash flow. ...

Is AbbVie a good investment?

AbbVie, with a market cap of over $300 billion, shows strong cash flow potential despite patent expirations, making it a valuable investment. The company reported strong 3Q financials, with adjusted diluted EPS at $3/share and nearly $15 billion in revenue, up 4%. ...

Is AbbVie in trouble?

Basically for every $1 AbbVie generates in revenues, it generates 41 cents in operating cash flow which is pretty impressive considering that many investors seem to think that this company is in trouble due to declining sales of some of its drugs. In recent years the company has been paying off its debt and reducing its leverage. ...

What is AbbVie's financial health?

Financial Resilience and Cash Flow Generation: AbbVie's financial health is a testament to its operational excellence. The company's net revenues have shown a steady increase, with a 3% reported growth and 4% on a constant currency basis. ...

What is the 3 year total return CAGR for AbbVie Inc (abbv)?

The 3 year total return compound annual growth rate for ABBV stock is 25.04%. What is the 5 year total return CAGR for AbbVie Inc (ABBV)? The 5 year total return compound annual growth rate for ABBV stock is 24.88%. What is the 10 year total return CAGR for AbbVie Inc (ABBV)? ...

What will AbbVie do in the next 5 years?

In the next five years, expect AbbVie to continue to compete in the disease areas that its pipeline and product mix are currently heavily focused around: immunology, neuroscience, and oncology. ...